Direktorat Registrasi ObatValid (Export Only)

SANBELAT

Claim this product
BPOM Number
LKE20222009
Approved
21 November 2024
Expiry
2 August 2025
Form
SERBUK INJEKSI LIOFILISASI; 8,571 MG

About This Registration

SANBELAT is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number LKE20222009. Its current registration status is Valid (Export Only), with the licence valid until 2 August 2025. The product is registered to SANBE FARMA and manufactured by SANBE FARMA - INDONESIA. BPOM first approved this registration in August 2020. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 VIAL @15 U
Department
Direktorat Registrasi Obat
Data Last Updated
13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

BLEOMYCIN SULFATE

Market Intelligence

Owner Portfolio
SANBE FARMA holds 554 BPOM registrations
Manufacturer Scale
SANBE FARMA - INDONESIA produces 490 registered products
Registration Age
Registered for 6 years, 1 month
Expiry Status
Expired 420 days ago

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1